The Fleury Group has successfully acquired the Marcelo Magalhães Laboratory in Recife, Pernambuco, for R$ 384.5 million, aimed at expanding its footprint and enhancing integrated healthcare services in the region.

Target Information

The Fleury Group has announced the complete acquisition of the Marcelo Magalhães Laboratory in Recife, Pernambuco, for an enterprise value of R$ 384.5 million, contingent upon the fulfillment of certain precedent conditions. The Marcelo Magalhães Laboratory boasts a 64-year legacy and is widely recognized as a benchmark in clinical analysis within the state of Pernambuco, operating 13 units as well as a mobile service in the Metropolitan Region of Recife. Over the last 12 months, the laboratory recorded a gross revenue of R$ 114 million.

This acquisition aims to significantly enhance the Fleury Group's footprint in Pernambuco, enlarging its service network to a total of 31 units in the metropolitan area. The addition of Marcelo Magalhães Laboratory will augment Fleury's existing capabilities in clinical analyses and imaging services, which it provides through its operational brands, a+ Medicina Diagnóstica and Diagmax.

Industry Overview in Pernambuco

The health sector in Brazil, particularly in the northeastern region, has been experiencing robust growth driven by changes in healthcare demands and increased access to servic